This website uses cookies

This website uses cookies to ensure you get the best experience. By using our website, you agree to our Privacy Policy

International In-house Counsel Journal logoInternational In-house Counsel Journal logo
Back to library search

Being Social: The FDA Pronounces on Interactive Promotional Media

Abstract

In the United States, consumers are increasingly turning to social media to obtain information about pharmaceutical products and devices, to research medical conditions, and obtain information about potential treatments, available support groups and other health-related information. Data from Manhattan Research (for the year 2013) indicates that social media influences the patient journey in unprecedented ways: for example, upwards of 20% of consumers surveyed were “strongly influenced” by social media when experiencing symptoms, after diagnosis, or when managing their condition. Social media has also influenced patients’ interactions with their doctors: 27% of consumers using social media reported that they asked a doctor to prescribe a generic instead of a brand as a result of health/medial information they found on-line, 12% asked a doctor to prescribe a brand, and 25% asked a doctor to prescribe any drug.

Author

Portrait image of Marianne Slivkova
Marianne Slivkova
Senior Corporate Counsel, Acorda Therapeutics, USA

Marianne Slivkova is Director, Legal, Commercial at Acorda Therapeutics. She is primarily responsible for providing legal advice on legal risk, interpretation of FDA advertising regulations, PDMA, healthcare fraud and abuse, product liability, privacy, antitrust statutes and regulations, as well as other federal and state laws, and company policies and procedures to U.S. marketing, sales and medical management, as well as advising on ex-US issues. Prior to joining Acorda, Ms. Slivkova was Senior Corporate Counsel at BMS, and during 2012, she served as the interim head of BMS’s Japanese legal department in Tokyo. Before becoming an in-house attorney, Ms. Slivkova was a Senior Litigation Associate at Moses & Singer in New York City, and at Dewey Ballantine LLP. Ms. Slivkova holds a Master’s of Public Health from the Harvard School of Public Health, a Juris Doctor degree from New York University School of Law, and a Bachelor’s Degree from Columbia College, Columbia University.

Company

Acorda Therapeutics logo

Acorda Therapeutics

Acorda’s mission is to develop therapies that restore function and improve the lives of people with neurological disorders.

Related Papers

Patent Strategies for Attenuated Pathogen Vaccines
Malaria is a major health concern for people traveling to and living in malaria-endemic areas, causing 249 million clinical cases and 608,000 deaths in 2022, numbers essentially unchanged over the...Read more
Portrait image of David Dolberg
David Dolberg
Senior Director of Intellectual Property, Sanaria Inc., USA
Ways to Avoid Having your Patents Cellected*
The Court of Appeals for the Federal Circuit caused frustrations when it decided to affirm the U.S. Patent Office’s findings that claims in four patents were unpatentable because they are...Read more
Portrait image of Tom Irving
Tom Irving
Partner, Marbury Law Group, USA
Portrait image of Michelle E. O'Brien
Michelle E. O'Brien
Partner, Marbury Law Group, USA
Portrait image of Xiaoguang Michelle Gao
Xiaoguang Michelle Gao
Associate VP - Assistant General Patent Counsel , Eli Lilly and Company, USA
Supported Studies Quid Pro Quo
Many pharmaceutical companies (hereinafter Companies or Company) recognize the importance of supporting external studies and the role they play in fulfilling patients’ needs. High standard ethical research conducted by external...Read more
Portrait image of Ann Turi
Ann Turi
Senior Legal Counsel, Legal and Compliance R&D and Medical Legal Team, Gsk, USA
Section 112 Requirements for Life Sciences Patents
35 U.S.C. §112(a) of the US Patent Act is one of the integral parts of the quid pro quo patent system that balances the benefit of disclosure of the invention...Read more
Portrait image of Anagha Tendulkar
Anagha Tendulkar
In-house Patent Counsel, Cipla, India